Sonic Incytes Medical Corp, proudly announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance ...

Artificial intelligence programs can help doctors and nurses predict hours earlier which ER patients will likely require ...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), headquartered in Massachusetts, is a global biopharmaceutical enterprise ...

Additionally, the FDA has granted a Priority Review for Revuforj’s supplemental New Drug Application (sNDA) in relapsed or ...

USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Aug. 12, 2025 /CNW/ — USA News Group News Commentary – Research and development of new AI-powered tech ...

Jon Walsh, founder, chief scientific officer, Unlearn, explains how regulators are clarifying best practices for integrating AI and digital twins into clinical research.

HistoIndex’s AI-based FibroSIGHT Plus’s launch coincides with the MASH space’s pharma market potential swelling across the ...

Recent news reports highlight uncertainty about pharmaceutical tariffs, an error-prone AI tool in use at the FDA, and scientific research funding in jeopardy.

The use of artificial intelligence for batch monitoring and digital twin development are redefining process control — ...

With advances in technology, there is a possibility that such videos could be digitally altered or even AI-generated, says ...

While DCTs failed to transform clinical research, artificial intelligence (AI)-powered study approaches are now fulfilling their promise within the non-interventional research space. Unified, digital ...

Respiree announced that it received a second FDA 510(k) clearance for its RS001 cardio-respiratory wearable device.